A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer-Reference-Cited by-同舟云学术

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Published:2013-11 Issue:2 Volume:82 Page:276-281
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ciuleanu T.,Tsai C.-M.,Tsao C.-J.,Milanowski J.,Amoroso D.,Heo D.S.,Groen H.J.M.,Szczesna A.,Chung C.-Y.,Chao T.-Y.,Middleton G.,Zeaiter A.,Klingelschmitt G.,Klughammer B.,Thatcher N.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Cancer statistics 2012;Siegel;CA Cancer J Clin,2012

3. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

4. Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed.: American College of Chest Physicians evidence-based clinical practice guidelines;Socinski;Chest,2013

5. A hybrid model of the role of VEGF binding in endothelial cell migration and capillary formation;Jain;Front Oncol,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer;Cancer Epigenetics and Nanomedicine;2024

2. Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study;Cancer Cell;2021-09

3. Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review;BMC Medicine;2021-04-08

4. Impact of body mass index on survival and serious adverse events in advanced non-small cell lung cancer treated with bevacizumab: a meta-analysis of randomized clinical trials;Current Medical Research and Opinion;2021-03-24

5. Efficacy and safety of anti-angiogenic drugs combined with erlotinib in the treatment of advanced non-small cell lung cancer: a meta-analysis of randomized clinical trials;Annals of Palliative Medicine;2021-03